Investor FAQ

Investor FAQ

Arcadia’s symbol on NASDAQ is RKDA.
Arcadia was founded in 2002.
Arcadia is headquartered in Davis, California. Our address is:

202 Cousteau Place, Suite 105
Davis, CA 95618
Phone: (530) 756-7077
Fax: (530) 756-7027
info@arcadiabio.com
Arcadia is a Delaware corporation.
Arcadia became a public company on May 15, 2015 and its IPO priced at $8.00 per share. The company is listed on NASDAQ as RKDA.
Arcadia does not offer a direct purchase program at this time.
Arcadia has a calendar year fiscal year. Its fiscal quarters are as follows: First Quarter: January 1 to March 31 Second Quarter: April 1 to June 30 Third Quarter: July 1 to September 30 Fourth Quarter: October 1 to December 31
Currently, Arcadia does not pay dividends, and hence does not offer a dividend reinvestment program.

Arcadia’s transfer agent is:

American Stock Transfer & Trust Company, LLC
(800) 937-5449 or (718) 921-8124
help@astfinancial.com
www.astfinancial.com
Arcadia’s auditor is Deloitte & Touche LLP.
Arcadia’s legal counsel is Weintraub Tobin.
As of December 31, 2018, we had 44 full-time employees.
Arcadia has two main offices and research facilities.
All news releases can be accessed on Arcadia’s web site through the News & Events link.
Documents filed with the SEC can be accessed through the Investor Relations page of the Arcadia web site.
For further information, please contact us at info@arcadiabio.com.